ResMed [ASX:RMD] Reports Revenue Growth of 16%
Medical devices and cloud applications developer ResMed has reached $1.4 billion in revenue, an increase of 16%, growing profits by 13% and non-GAAP operating profits by 14%.
Stay updated with breaking news from Rd Research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Medical devices and cloud applications developer ResMed has reached $1.4 billion in revenue, an increase of 16%, growing profits by 13% and non-GAAP operating profits by 14%.
Our Space Café WebTalk “33 minutes with Paul Liias - Why should you go to Tallinn, Estonia in October?” Took place on Tuesday, 18th October.
Battery Management System Market 2022: Growing Need for EVs Drives the Share at a 20.5% CAGR by Industry Size, Technology and Global Trends to 2030
Yes, we have health care, but at what cost?
Apple is a cash flow machine. It once again reported stable quarterly results and expects sales should accelerate. Read more about AAPL here.